For: | Sherman KE, Kang M, Sterling R, Umbleja T, Marks K, Kiser JJ, Alston-Smith B, Greaves W, Butt AA, the ACTG 5294 BIRTH Study Team. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World J Hepatol 2017; 9(4): 217-223 [PMID: 28217259 DOI: 10.4254/wjh.v9.i4.217] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v9/i4/217.htm |
Number | Citing Articles |
1 |
Kenneth E. Sherman, Susan D. Rouster, Minhee Kang, Triin Umbleja, Richard Sterling, Adeel A. Butt. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive Diseases and Sciences 2018; 63(11): 2969 doi: 10.1007/s10620-018-5278-y
|
2 |
Jennifer J. Kiser, Darlene Lu, Susan L. Rosenkranz, Gene D. Morse, Robin DiFrancesco, Kenneth E. Sherman, Adeel A. Butt. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s. Drugs in R&D 2017; 17(4): 557 doi: 10.1007/s40268-017-0205-9
|
3 |
Jiali Liu, Minghong Yao, Mingqi Wang, Wan Jie, Yanmei Liu, Xiaochao Luo, Jiayidaer Huan, Kelin Deng, Ke Deng, Kang Zou, Ying Zhang, Ling Li, Xin Sun. Design, Conduct, and Analysis of Externally Controlled Trials. JAMA Network Open 2025; 8(9): e2530277 doi: 10.1001/jamanetworkopen.2025.30277
|